Bluecrest Wellness Cancer screening

Female Cancer + Complete (over 40s)

The Female Cancer Risk package plus added heart-focused checks: an ECG, peripheral arterial disease test, Lipoprotein(a) and a heart disease and stroke risk assessment.

  • Doctor reviewed
  • Female
Sample
Mixed
Collection
Venous draw at local venue plus at-home self-collection kit(s)
Results in
3–8 days
Biomarkers
42
Doctor reviewed
Yes
Tests for
  • Lipoprotein (a)
  • Biometric Analysis
  • Blood Health Markers
  • Bone Health, Energy & Muscles
  • Bowel Cancer Risk (qFIT test)
  • Cervical Cancer Risk (HPV test)
  • Cholesterol & Advanced Diabetes
  • Essential Proteins and Iron
  • Heart Disease & Stroke Risk
  • Heart Rhythm (ECG test)
  • Immune System
  • Kidney Function
  • +6 more

Test specifications

Provider
Bluecrest Wellness
Sample type
mixed
Collection method
venous draw at local venue plus at-home self-collection kit(s)
Turnaround time
3–8 days
Biomarkers tested
42
At-home test
No
Doctor reviewed
Yes
Gender focus
Female

What's tested

18 biomarkers as listed by Bluecrest Wellness, of 42 in total.

Cholesterol status

  • Lipoprotein (a)
  • Biometric Analysis
  • Blood Health Markers
  • Bone Health, Energy & Muscles
  • Bowel Cancer Risk (qFIT test)
  • Cervical Cancer Risk (HPV test)
  • Cholesterol & Advanced Diabetes
  • Essential Proteins and Iron
  • Heart Disease & Stroke Risk
  • Heart Rhythm (ECG test)
  • Immune System
  • Kidney Function
  • Liver Function
  • Lung Function Check for COPD
  • Peripheral Arterial Disease (PAD)
  • Stomach Cancer Risk (H Pylori)
  • Thyroid Function
  • Urinalysis

About this test

Female Cancer + Complete (over 40s) combines the Female Cancer Risk package, covering bowel, cervical and stomach cancer risk markers alongside liver, kidney, thyroid and immune function, with the extra heart-focused tests from Bluecrest's Complete package: an ECG heart rhythm check for atrial fibrillation, a peripheral arterial disease test, a heart disease and stroke risk assessment for metabolic syndrome, and a Lipoprotein(a) test for arterial plaque risk. In total it covers 42 biomarkers.

That marker count places it in the 96th percentile for clinical depth among the cancer screening tests we track, the broadest package in that category in our data. As with the standalone Female Cancer Risk package, there is no directly comparable package to benchmark the £519 price against.

Results and follow-up score well because, as with the Female Cancer Risk package, this includes a doctor review and a private consultation, plus access to Perci Health's cancer nursing team if a cancer-risk result comes back amber or red. As Bluecrest notes, none of the cancer-risk elements are diagnostic on their own.

Who is it for?

This suits women aged 40 and over who want the broadest single package Bluecrest offers for women, combining cancer-risk screening with a heart-focused health check, and who are comfortable with a higher price for that scope. If you only want the cancer-risk element without the extra heart tests, the standalone Female Cancer Risk package covers the same cancer-risk markers for £319. Bluecrest does not recommend this package under age 40.

How it works

Collection is mixed: a venous blood draw at a local Bluecrest venue, at-home self-collection kits for certain markers, and in-person measurements for the ECG and peripheral arterial disease checks. Bluecrest states results are typically returned in around 3 to 8 days. Results are reviewed by a doctor, with a private consultation by phone or webcam, and access to Perci Health's cancer nursing support if a cancer-risk result is amber or red.

Pros & cons

Pros

  • Covers 42 biomarkers, the broadest package for women in Bluecrest's range.
  • Adds heart-focused tests, ECG, peripheral arterial disease and Lipoprotein(a), on top of the cancer-risk markers.
  • Includes a doctor review and private consultation, unlike most individual Bluecrest tests.
  • Access to Perci Health cancer nursing support if a cancer-risk result is amber or red.

Cons

  • At £519, it is Bluecrest's most expensive package here, with no comparable package to check value against.
  • Not recommended for women under 40.
  • Cancer-risk elements are not diagnostic on their own and may need further GP investigation.

Our editorial score

Compare Health Test Score Broadest package for women, at a premium price
Editorial confidence: 10.0/10

For £519, this combines everything in the Female Cancer Risk package with the Complete health MOT's extra heart tests, an ECG, a peripheral arterial disease check, Lipoprotein(a) and a heart disease and stroke risk assessment, across 42 biomarkers in total. There's no comparable package in our data to weigh the price against, but it carries the same doctor review and consultation as the Female Cancer Risk package.

Score breakdown

  • Clarity and documentation 8.0/10

    The listing publishes a detailed description, some of the biomarkers by name, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 10.0/10

    42 biomarkers, placing it in the 96th percentile of cancer screening tests we track.

  • Collection convenience 7.0/10

    A finger-prick sample you take at home; with a venous or clinic option as well; results in around 8 days, slower than similar tests.

  • Results and follow-up 7.0/10

    Results are reviewed by a doctor; the provider does not describe the report format.

  • Trust signals 9.5/10

    Trustpilot 4.7 from 6,787 reviews; accredited lab (UKAS ISO 15189 own lab); CQC registered; trading 14+ years.

  • Value for money 6.0/10

    £519.00; no comparable tests to benchmark against yet.

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

More in Cancer screening

View all →
Selph

qFIT Bowel Cancer Screening Test

Priced close to the FIT test group median

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10
£59.00
Full review →